BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 8401133)

  • 1. Cost-utility analysis.
    Robinson R
    BMJ; 1993 Oct; 307(6908):859-62. PubMed ID: 8401133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationing health care resources. Is the quality-adjusted life-year a helpful guide?
    Warren JM
    Can Fam Physician; 1994 Jan; 40():123-4, 127-8. PubMed ID: 8312748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-utility analysis from a societal perspective.
    Johannesson M; O'Conor RM
    Health Policy; 1997 Mar; 39(3):241-53. PubMed ID: 10165464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QALY league tables: handle with care.
    Gerard K; Mooney G
    Health Econ; 1993 Apr; 2(1):59-64. PubMed ID: 8269048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why health economics is economical with the truth.
    Munro J
    Health Care Anal; 1993 Nov; 1(2):197-9. PubMed ID: 10135601
    [No Abstract]   [Full Text] [Related]  

  • 6. The QALY: a guide for the public health physician.
    Petrou S; Renton A
    Public Health; 1993 Sep; 107(5):327-36. PubMed ID: 8248467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care economic analyses and value-based medicine.
    Brown MM; Brown GC; Sharma S; Landy J
    Surv Ophthalmol; 2003; 48(2):204-23. PubMed ID: 12686305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allocating resources to health care: is the QALY (Quality Adjusted Life Year) a technical solution to a political problem?
    Carr-Hill RA
    Int J Health Serv; 1991; 21(2):351-63. PubMed ID: 2071312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of obesity on cost per quality-adjusted life years gained following anterior cervical discectomy and fusion in elective degenerative pathology.
    Chotai S; Sielatycki JA; Parker SL; Sivaganesan A; Kay HL; Stonko DP; Wick JB; McGirt MJ; Devin CJ
    Spine J; 2016 Nov; 16(11):1342-1350. PubMed ID: 27394664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some guidelines on the use of cost effectiveness league tables.
    Mason J; Drummond M; Torrance G
    BMJ; 1993 Feb; 306(6877):570-2. PubMed ID: 8461776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility in practice: a policy maker's guide to the state of the art.
    Gerard K
    Health Policy; 1992 Jul; 21(3):249-79. PubMed ID: 10120196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economics, QALYs and medical ethics: a practical agenda?
    Robinson R
    Health Care Anal; 1995 Aug; 3(3):229-32. PubMed ID: 10151643
    [No Abstract]   [Full Text] [Related]  

  • 13. The DH register of cost-effectiveness studies: content and quality.
    Mason J; Drummond M
    Health Trends; 1995; 27(2):50-6. PubMed ID: 10153159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economics, QALYs and medical ethics--a health economist's perspective.
    Williams A
    Health Care Anal; 1995 Aug; 3(3):221-6. PubMed ID: 10151641
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-utility analysis of cataract surgery in the second eye.
    Busbee BG; Brown MM; Brown GC; Sharma S
    Ophthalmology; 2003 Dec; 110(12):2310-7. PubMed ID: 14644712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
    Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
    Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery for degenerative cervical myelopathy: a patient-centered quality of life and health economic evaluation.
    Witiw CD; Tetreault LA; Smieliauskas F; Kopjar B; Massicotte EM; Fehlings MG
    Spine J; 2017 Jan; 17(1):15-25. PubMed ID: 27793760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verteporfin photodynamic therapy cohort study: report 3: cost effectiveness and lessons for future evaluations.
    Grieve R; Guerriero C; Walker J; Tomlin K; Langham J; Harding S; Chakravathy U; Carpenter J; Reeves BC;
    Ophthalmology; 2009 Dec; 116(12):2471-77.e1-2. PubMed ID: 19948278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QALYs (Quality Adjusted Life Years): a nurse's view.
    Holmes CA
    Int J Health Care Qual Assur; 1993; 6(5):17-23. PubMed ID: 10131453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.